Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $68,161.86 +2.48%
Ethereum $1,976.32 +2.62%
BNB $630.59 +4.77%
Optimism $0.13 +3.60%
Arbitrum $0.10 +8.15%
Solana $85.35 +4.13%
Polygon $0.22 +2.77%
Cosmos $2.35 +0.57%
Avalanche $9.32 +4.14%

Bitcoin $68,161.86 +2.48%
Ethereum $1,976.32 +2.62%
BNB $630.59 +4.77%
Optimism $0.13 +3.60%
Arbitrum $0.10 +8.15%
Solana $85.35 +4.13%
Polygon $0.22 +2.77%
Cosmos $2.35 +0.57%
Avalanche $9.32 +4.14%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B